Medline ®
Abstract for Reference
47
of 'Prevention of malaria infection in travelers'
47
TI
Making malaria-treatment policy in the face of drug resistance.
AU
Bloland PB; Ettling M
SO
Ann Trop Med Parasitol. 1999 Jan;93(1):5-23.
The threat, development, spread, and intensification of antimalarial drug resistance are posing tremendous challenges to malaria-control activities throughout the world. Fundamental aspects of these activities are the identification and promotion of safe and effective therapy for acute malarial illness. A major tool in providing guidance on appropriate therapy is the national malaria-therapy policy, which describes antimalarial drugs available for use in a given country, their relative efficacy, and how best to use them in a variety of settings, from the community to the referral hospital. This review describes some of the factors that need to be considered in the development of a national, antimalarial drug policy as well as those that have impeded timely development of national policies, especially in sub-Saharan Africa.
AD
Malaria Epidemiology Section, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. pbb1@cdc.gov
